Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 5Prostatic Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Sarcopenia 1Obesity 1Lung Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Radiotherapy 6Magnetic Resonance Spectroscopy 5Radiation 4Neoadjuvant Therapy 4Methods 3Mastectomy, Segmental 3High-Energy Shock Waves 3Early Intervention, Educational 3Counseling 3Biopsy 3Tamoxifen 2Surveys and Questionnaires 2Standard of Care 2Radiotherapy, Conformal 2Psychiatric Rehabilitation 2Practice Guidelines as Topic 2Lapatinib 2Immunohistochemistry 2Genetic Testing 2Diet 2Cryosurgery 2Chemotherapy, Adjuvant 2Caregivers 2Brachytherapy 2perflutren 1black cohosh root extract 1Zolpidem 1Yoga 1Venlafaxine Hydrochloride 1Trastuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinoma, Intraductal, Noninfiltrating × Soybean Proteins × Clear all
NCT01219075 2023-11-18

Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer

University of Southern California

Phase NA Completed
110 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡